{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Restrict the search for
irinotecan
to a specific field?
Status:
Possibly Marketed Outside US
Source:
ANDA070433
(1987)
Source URL:
First approved in 1987
Source:
ANDA070433
Source URL:
Class (Stereo):
CHEMICAL (ACHIRAL)
Water O-15 as a diagnostic agent that was used in H215O-positron emission tomography/magnetic resonance imaging for noninvasive measurement of cerebral blood flow.
Status:
Possibly Marketed Outside US
Source:
21 CFR 333A
(2018)
Source URL:
First approved in 1978
Source:
K-PhosNo. 2 by Beach Products, Inc.
Source URL:
Class (Stereo):
CHEMICAL (ACHIRAL)
Status:
Possibly Marketed Outside US
Source:
NCT01290055: Phase 4 Interventional Completed Yellow Fever
(2019)
Source URL:
Class (Stereo):
CHEMICAL (ACHIRAL)
Deuterium Oxide (heavy water) is a stable, non-radioactive isotopic form of water. The heavy water is used as a moderator of neutrons in nuclear power plants. In the laboratory, heavy water is employed as an isotopic tracer in studies of chemical and biochemical processes. Deuterium oxide acts as a true temperature-modifying agent. It protects mammalian cells against hyperthermic damage. Plant cell biologists had made a similar observation. Regarding human health, deuterium oxide has a wide range of proposed applications, such as therapeutic agent against human pancreatic cancer, determination of total body water (TBW), and enhancement of thermal stability of macromolecules, cells and tissue. Other applications are: treatment of hypertension, treatment of virus-based diseases of the respiratory tract and treatment of herpes virus-based diseases of the skin.
Status:
US Approved Rx
(2013)
First approved in 1958
Class:
MIXTURE
